本文選題：痤瘡2號(hào)方 + IPL　； 參考：《山東中醫(yī)藥大學(xué)》2017年碩士論文

【摘要】：目的:觀察口服中藥痤瘡2號(hào)方聯(lián)合IPL治療尋常痤瘡后紅斑的臨床療效,為尋常痤瘡后紅斑尋求一種療效好、副作用少、復(fù)發(fā)率低的治療新方法。方法:隨機(jī)選取74例門診病例,治療組37例,給予口服中藥痤瘡2號(hào)方聯(lián)合IPL治療,對(duì)照組37例,僅應(yīng)用IPL治療儀治療。首次治療前(第1天)、第三次治療前(第28天)和末次治療2周后(第56天)分別拍照記錄,根據(jù)紅斑顏色、數(shù)量、大小、分布情況做出紅斑綜合積分評(píng)定,并以紅斑綜合積分減少率作為療效指數(shù)評(píng)定臨床療效。結(jié)果:以第56天評(píng)定結(jié)果作為最終結(jié)果,治療組和對(duì)照組的痊愈率分別為37.8%和16.2%,愈顯率分別為83.3%和54.1%,總有效率分別是100%和83.8%,兩組比較差異有統(tǒng)計(jì)學(xué)意義(P0.05),治療組在紅斑顏色、數(shù)量、大小方面的療效均優(yōu)于對(duì)照組。治療組和對(duì)照組不良反應(yīng)出現(xiàn)的概率分別為5.41%和13.51%,兩組比較差異無統(tǒng)計(jì)學(xué)意義(P0.05),提示兩組不良反應(yīng)無差異。治療組和對(duì)照組的復(fù)發(fā)率分別為14.29%和66.67%,兩組比較差異有統(tǒng)計(jì)學(xué)意義(P0.05),提示治療組復(fù)發(fā)率低。結(jié)論:口服中藥痤瘡2號(hào)方聯(lián)合IPL治療尋常痤瘡后紅斑療效確切,副作用少,復(fù)發(fā)率低,使患者恢復(fù)自信,進(jìn)而提高身心健康和生活質(zhì)量,體現(xiàn)了中醫(yī)中藥的特色和優(yōu)勢(shì),值得進(jìn)一步推廣。
[Abstract]:Objective: to observe the clinical effect of Acne No.2 prescription combined with IPL in the treatment of erythema vulgaris after acne vulgaris, and to seek a new method for treating Erythema vulgaris with good curative effect, less side effect and low recurrence rate. Methods: a total of 74 outpatients were randomly selected as treatment group (n = 37) and treated with traditional Chinese medicine acne prescription No. 2 combined with IPL. The control group (n = 37) was treated with IPL only. Before the first day of treatment (day 1), before the third treatment (day 28) and 2 weeks after the last treatment (day 56), they were photographed and evaluated according to the color, quantity, size and distribution of erythema. The reduction rate of erythema integral was used as the curative effect index to evaluate the clinical curative effect. Results: the cure rates of the treatment group and the control group were 37.8% and 16.2%, respectively, and the effective rates were 83.3% and 54.1%, respectively. The total effective rates were 100% and 83.8%, respectively. The difference between the two groups was statistically significant (P 0.05). The effect of quantity and size was better than that of control group. The probability of adverse reactions in the treatment group and the control group were 5.41% and 13.51%, respectively. There was no significant difference between the two groups (P 0.05), indicating that there was no difference in the adverse reactions between the two groups. The recurrence rates of the treatment group and the control group were 14.29% and 66.67%, respectively. The difference between the two groups was statistically significant (P 0.05), indicating that the recurrence rate of the treatment group was low. Conclusion: the treatment of erythema after acne vulgaris by oral acne prescription No. 2 and IPL is effective, with less side effects and low recurrence rate, which can restore the confidence of the patients, improve the physical and mental health and the quality of life, and reflect the characteristics and advantages of traditional Chinese medicine in the treatment of erythema vulgaris. It is worth further popularizing.
【學(xué)位授予單位】：山東中醫(yī)藥大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2017
【分類號(hào)】：R758.733

【參考文獻(xiàn)】

相關(guān)期刊論文 前10條

1 梁俊芳;王用峰;;強(qiáng)脈沖光聯(lián)合中藥倒模治療面部痤瘡紅斑及色素沉著的臨床療效[J];現(xiàn)代中醫(yī)藥;2016年06期

2 蘇虹;譚雅心;石航;何黎;楊智;;強(qiáng)脈沖光及595nm染料激光治療痤瘡后面部紅斑療效的自身對(duì)比研究[J];中國激光醫(yī)學(xué)雜志;2016年05期

3 鄭勇鳳;王佳婧;傅超美;王建新;;黃芩的化學(xué)成分與藥理作用研究進(jìn)展[J];中成藥;2016年01期

4 楊婷婷;邵明娟;石群;謝士娟;楊慧;;關(guān)于全國大學(xué)生痤瘡發(fā)病率及影響因素的調(diào)查[J];臨床醫(yī)學(xué)研究與實(shí)踐;2016年01期

5 張俊紅;陶琳琳;孫玉蓮;;當(dāng)歸多糖和貢菊黃酮面膜的研究[J];廣東化工;2015年24期

6 李娟;;淺析強(qiáng)脈沖光在面部痤瘡后紅斑及炎性色素沉著治療中的應(yīng)用[J];世界最新醫(yī)學(xué)信息文摘;2015年A4期

7 李平平;梁偉;張真;李瑩;高靜;馬躍;;長(zhǎng)脈寬1064nm Nd:YAG激光治療中重度痤瘡伴痤瘡后紅斑的療效[J];山東大學(xué)學(xué)報(bào)(醫(yī)學(xué)版);2015年11期

8 任建文;應(yīng)朝霞;王永賢;馬慧群;周俊;李蕊蓮;蘇慧;劉艷;;染料窄譜脈沖光(Dye-PL)治療痤瘡后紅斑患者40例療效分析[J];中國皮膚性病學(xué)雜志;2015年09期

9 段宏偉;王新宇;湯恭鋒;;540nm強(qiáng)脈沖光聯(lián)合清熱散結(jié)膠囊治療痤瘡紅斑療效觀察[J];中國美容醫(yī)學(xué);2015年14期

10 瞿璐;王濤;董勇U，

本文編號(hào)：1847994